momentum2play,
You are right that we don’t “know” but the party is being planned for by quite a few of Dr. Linda Liau’s colleagues at SNO and I don’t think they plan to be disappointed. The news window for NWBO keeps getting tighter every day and good news, in the form of top line data, we can reasonably assume is in Linda Powers hands. I think Dr. Ashkan and friends have been made aware of what kind of opposition this company is truly facing by now and I expect his clout to come into play with timing from all things UK including the Lancet. The princess is about to be coronated queen by the neuro oncology community and anyone not in line to celebrate I suspect will be outed. Everyone, including big pharma, has had time to make adjustments for their decisions not to pursue this line of approach earlier. Linda Powers made this line of approach her priority and, with her God given gifts and talents, to get Dr. Linda Liau to this point when no one else would take up the cause and that will never be forgotten. By all indications what is about to take place has been a well planned for event, without compromising patient access, just like those 17 missing SOC/placebo patients. I may be wrong and willing to admit so but at this point I have no good reason to believe otherwise from what I see forming. Best wishes.
AI
Market Data 
Markets 
